Sudeep Pharma Ltd.
Fundamentals
- Market cap
- ₹7,605 cr
- P/E
- 70.70×
- ROE
- 28.13%
- Debt / equity
- 0.27
- 52-week range
- 524.05 — 795.00
The timeline — 3 notes on Sudeep Pharma Ltd.
May 2026
- 22 May 26 · 12:08 IST Brief Brief · Concalls
Sudeep Pharma revenue climbs 28%, but project delays and working capital bite
FY26 profits hit ₹174.3 cr as management battles energy-linked commissioning delays at its Nandesari facility.
- 21 May 26 · 16:21 IST Brief Brief · Earnings
Sudeep Pharma FY26: Revenue up 28%, PAT at ₹174 cr
Speciality ingredients segment drives strong performance; company recommends ₹1.50 per share final dividend.
- 21 May 26 · 16:07 IST Brief Brief · Earnings
Sudeep Pharma wraps FY26 with 28% revenue growth, 26% PAT jump
Audited annual numbers confirm strong speciality ingredients demand and NSS Ireland contribution; final dividend of ₹1.50 per share recommended.